Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy
Cancer of the skin is by far the most common of all cancers. Although the incidence of melanoma is relatively low among skin cancers, it can account for a high number of skin cancer deaths. Since the start of deeper insight into the mechanisms of melanoma tumorigenesis and their strong interaction w...
Main Authors: | Beáta Biri-Kovács, Zoltán Bánóczi, Anitha Tummalapally, Ildikó Szabó |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/2/452 |
Similar Items
-
Antitumor Peptide-Based Vaccine in the Limelight
by: Takumi Kumai, et al.
Published: (2022-01-01) -
Chitosan-Poly (I:C)-PADRE Based Nanoparticles as Delivery Vehicles for Synthetic Peptide Vaccines
by: Jorge F. Correia-Pinto, et al.
Published: (2015-09-01) -
Immunomodulatory Peptides as Vaccine Adjuvants and Antimicrobial Agents
by: Shiva Hemmati, et al.
Published: (2024-02-01) -
Targeting the Melanocortin 1 Receptor in Melanoma: Biological Activity of α-MSH–Peptide Conjugates
by: Ildikó Szabó, et al.
Published: (2024-01-01) -
Peptide Vaccine: Progress and Challenges
by: Weidang Li, et al.
Published: (2014-07-01)